Skip to main content

Senju DRC A Double-Masked, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability, and Efficacy of MT-0814 for the Treatment of Patients with Age-Related Macular Degeneration

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Senju Pharmaceutical Co, Ltd.

Start Date

April 11, 2019

End Date

May 26, 2021
 

Administered By

Ophthalmology

Awarded By

Senju Pharmaceutical Co, Ltd.

Start Date

April 11, 2019

End Date

May 26, 2021